Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Children`S Medical Center Corporation has 6 pending office actions in Biotechnology & Pharmaceuticals. The docket includes 6 distinct examiners and 5 distinct art units, indicating broad examiner distribution with limited art-unit overlap.
NEAL, TIMOTHY JAY is the busiest examiner, with 1 pending matter. Counsel should use centralized deadline and issue tracking while tailoring substantive responses to each examination assignment.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting only | 2 (33%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEAL, TIMOTHY JAY | 1 | 78.0% | +13.2% |
| RIGA, MICHAEL ANGELO | 1 | 56.2% | +63.0% |
| MEYERING, SHABANA SHABBEER | 1 | 68.5% | +45.1% |
| SIPPEL, RACHEL T | 1 | 52.5% | +58.2% |
| PARAS JR, PETER | 1 | 9.1% | +7.7% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +12.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17430822 | Treating Heart Failure | PARAS JR, PETER | 100d overdue |
| 18968775 | METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS | RIGA, MICHAEL ANGELO | — |
| 18214333 | Nucleic Acids That Manipulate Immune Pathways | MEYERING, SHABANA SHABBEER | — |
| 17273937 | PAPD5 INHIBITORS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17603646 | AEROSOLIZED COMPOSITIONS COMPRISING MITOCHONDRIA AND METHODS OF USE THEREOF | SIPPEL, RACHEL T | 33d |
| 19081947 | INTERVENTIONAL DEVICE WITH ADJUSTABLE CONFIGURATION | NEAL, TIMOTHY JAY | — |
| 18968775 | METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS | RIGA, MICHAEL ANGELO | — |
| 18214333 | Nucleic Acids That Manipulate Immune Pathways | MEYERING, SHABANA SHABBEER | — |
| 17273937 | PAPD5 INHIBITORS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | — |
| Art Unit | Apps |
|---|---|
| 3795 | 1 |
| 1635 | 1 |
| 3785 | 1 |
| 1632 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19081947 | INTERVENTIONAL DEVICE WITH ADJUSTABLE CONFIGURATION | NEAL, TIMOTHY JAY | 3795 | DP | Non-Final OA | — | Pending | Mar 17, 2025 |
| 18968775 | METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS | RIGA, MICHAEL ANGELO | — | §102§112Other | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18214333 | Nucleic Acids That Manipulate Immune Pathways | MEYERING, SHABANA SHABBEER | 1635 | §103§112 | Non-Final OA | — | Pending | Jun 26, 2023 |
| 17603646 | AEROSOLIZED COMPOSITIONS COMPRISING MITOCHONDRIA AND METHODS OF USE THEREOF | SIPPEL, RACHEL T | 3785 | §103 | Final Rejection | 33d | Pending | Oct 14, 2021 |
| 17430822 | Treating Heart Failure | PARAS JR, PETER | 1632 | DP | Final Rejection | 100d overdue | Pending | Aug 13, 2021 |
| 17273937 | PAPD5 INHIBITORS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | 1626 | §103§112 | Final Rejection | — | Pending | Mar 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChildren`S Medical Center Corporation has 6 pending office actions as of October 2026, spread across 5 art units and 6 examiners.
Timothy Jay Neal has the most, with 1 of Children`S Medical Center Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
